The initial studies regarding A3A were done in cell lines, yeast cells or by retroactively analysing cancer genome databases for mutations without specifically examining the A3 expression patterns in A3B-null tumour cells [4,118,152,160]. The gene discussed is APOBEC3B; the disease is neoplasm.